Business
RenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To Wounds
RenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To Wounds.

About this update from Renovacare, Inc.
[{"type":"text","content":"\n \n RenovaCare, Inc., (RCAR), developer of the patented CellMist™ and \n SkinGun™ technologies* for isolating and spraying a patient’s own stem \n cells onto burns and wounds for rapid self-healing, today announced that \n the company has bolstered its patent portfolio with the issuance of a \n United States patent for its novel SkinGun™ device. The United States \n Patent and Trademark Office has granted an additional 30-month extension \n for the patent, providing protection beyond the year 2035.\n \n\nThis Smart News Release features multimedia. View the full release here: \nhttp://www.businesswire.com/news/home/20161206005236/en/\n\n \n \n RenovaCare President and CEO, Thomas Bold, holds patented stem cell spray device, SkinGun (Photo: Business Wire) \n\n\n \n The issuance of the United States patent reinforces the company’s \n current patent protections in Germany.\n \n \n “This formal intellectual property strengthens our competitive position \n in the marketplace and supports our long-standing conviction that our \n technology is a novel therapeutic medical device for isolating and \n spraying human stem cells on to serious burns and wounds,” said Thomas \n Bold, President and CEO of RenovaCare, Inc.\n \n \n These RenovaCare patents provide exclusive rights for its SkinGun™ \n device, including the exclusion of other developers from making, \n copying, using, or selling the invention unless they have obtained a \n license to do so.\n \n \n This announcement comes on the heels of world-leading expert in the \n isolation of specific stem cells ideal for spraying onto burns and \n wounds, Dr. Roger Esteban-Vives, joining the company as Director of Cell \n Sciences.\n \n \n Independent test results conducted by one of the world’s largest \n university hospitals show that RenovaCare SkinGun™ achieves the ‘gold \n standard’ when it comes to viability for skin regeneration. Cell \n viability is essential to regenerating skin for burns, wounds, and \n cosmetic applications. Data confirmed that human skin stem cells sprayed \n with the company’s patented SkinGun™ maintained 97.3% viability.\n \n \n *RenovaCare products are currently in development and are not available \n for sale in the United States.\n \n \n About RenovaCare\n \n \n RenovaCare,...